Cargando…
Mononostril versus Binostril Endoscopic Transsphenoidal Approach for Pituitary Adenomas: A Systematic Review and Meta-Analysis
BACKGROUND: Over the past several decades, the endoscopic endonasal transsphenoidal approach (EETA) has gradually become a preferred option of pituitary adenomas surgery because of its minimal invasiveness and high efficiency. However, some EETA operations were performed through one nostril (mononos...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849742/ https://www.ncbi.nlm.nih.gov/pubmed/27124276 http://dx.doi.org/10.1371/journal.pone.0153397 |
_version_ | 1782429591429709824 |
---|---|
author | Wen, Guodao Tang, Chao Zhong, Chunyu Li, Xiang Li, Junyang Li, Liwen Yang, Youqing Ma, Chiyuan |
author_facet | Wen, Guodao Tang, Chao Zhong, Chunyu Li, Xiang Li, Junyang Li, Liwen Yang, Youqing Ma, Chiyuan |
author_sort | Wen, Guodao |
collection | PubMed |
description | BACKGROUND: Over the past several decades, the endoscopic endonasal transsphenoidal approach (EETA) has gradually become a preferred option of pituitary adenomas surgery because of its minimal invasiveness and high efficiency. However, some EETA operations were performed through one nostril (mononostril), while other EETA operations were performed through both nostrils (binostril). Therefore, we conducted this study to compare the pros and cons of these two methods in an attempted to confirm which method is more effective. METHODS: We executed a systematic literature search of PubMed, the Cochrane Library, and the Web of Science and Medline (1992–2015). The language is limited to English and all studies should meet the inclusion criteria. Comparisons were made for postoperative outcomes, complications, and other relevant parameters between the mononostril and the binostril group. Statistical analyses of categorical variables were undertaken by the use of Stata 12.0 and SPASS 19.0. RESULTS: Thirty studies, involving 4805 patients, were included. The two groups had similar results in GTR rate (included GTR rate of macroadenomas), hormonal remission rate, improvement in visual function, postoperative CSF leak, permanent diabetes insipidus, meningitis, and sinusitis. The binostril group had less temporary diabetes insipidus (2.9% vs. 5.3%, p = 0.022), less anterior pituitary insufficiency (2.3% vs. 6.4%, p = 0.000) and few hospitalization days (3.2 days vs. 4.4 days, p<0.05) than the mononostril group. However, the mononostril group had less rate of epistaxis (0.4% vs. 1.5%, p = 0.008) than the binostril group. For invasive macroadenomas, the binostril group seem to demonstrate a tendency towards better outcomes though there was no subgroup analysis between the two groups. CONCLUSION: The binostril approach had less temporary diabetes insipidus, anterior pituitary insufficiency, and a shorter length of hospital stay, although they demonstrated a higher rate of epistaxis than the mononstril group. Additionally, the binostril group seemed to suggest a tendency towards better outcomes for invasive macroadenomas. |
format | Online Article Text |
id | pubmed-4849742 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-48497422016-05-07 Mononostril versus Binostril Endoscopic Transsphenoidal Approach for Pituitary Adenomas: A Systematic Review and Meta-Analysis Wen, Guodao Tang, Chao Zhong, Chunyu Li, Xiang Li, Junyang Li, Liwen Yang, Youqing Ma, Chiyuan PLoS One Research Article BACKGROUND: Over the past several decades, the endoscopic endonasal transsphenoidal approach (EETA) has gradually become a preferred option of pituitary adenomas surgery because of its minimal invasiveness and high efficiency. However, some EETA operations were performed through one nostril (mononostril), while other EETA operations were performed through both nostrils (binostril). Therefore, we conducted this study to compare the pros and cons of these two methods in an attempted to confirm which method is more effective. METHODS: We executed a systematic literature search of PubMed, the Cochrane Library, and the Web of Science and Medline (1992–2015). The language is limited to English and all studies should meet the inclusion criteria. Comparisons were made for postoperative outcomes, complications, and other relevant parameters between the mononostril and the binostril group. Statistical analyses of categorical variables were undertaken by the use of Stata 12.0 and SPASS 19.0. RESULTS: Thirty studies, involving 4805 patients, were included. The two groups had similar results in GTR rate (included GTR rate of macroadenomas), hormonal remission rate, improvement in visual function, postoperative CSF leak, permanent diabetes insipidus, meningitis, and sinusitis. The binostril group had less temporary diabetes insipidus (2.9% vs. 5.3%, p = 0.022), less anterior pituitary insufficiency (2.3% vs. 6.4%, p = 0.000) and few hospitalization days (3.2 days vs. 4.4 days, p<0.05) than the mononostril group. However, the mononostril group had less rate of epistaxis (0.4% vs. 1.5%, p = 0.008) than the binostril group. For invasive macroadenomas, the binostril group seem to demonstrate a tendency towards better outcomes though there was no subgroup analysis between the two groups. CONCLUSION: The binostril approach had less temporary diabetes insipidus, anterior pituitary insufficiency, and a shorter length of hospital stay, although they demonstrated a higher rate of epistaxis than the mononstril group. Additionally, the binostril group seemed to suggest a tendency towards better outcomes for invasive macroadenomas. Public Library of Science 2016-04-28 /pmc/articles/PMC4849742/ /pubmed/27124276 http://dx.doi.org/10.1371/journal.pone.0153397 Text en © 2016 Wen et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Wen, Guodao Tang, Chao Zhong, Chunyu Li, Xiang Li, Junyang Li, Liwen Yang, Youqing Ma, Chiyuan Mononostril versus Binostril Endoscopic Transsphenoidal Approach for Pituitary Adenomas: A Systematic Review and Meta-Analysis |
title | Mononostril versus Binostril Endoscopic Transsphenoidal Approach for Pituitary Adenomas: A Systematic Review and Meta-Analysis |
title_full | Mononostril versus Binostril Endoscopic Transsphenoidal Approach for Pituitary Adenomas: A Systematic Review and Meta-Analysis |
title_fullStr | Mononostril versus Binostril Endoscopic Transsphenoidal Approach for Pituitary Adenomas: A Systematic Review and Meta-Analysis |
title_full_unstemmed | Mononostril versus Binostril Endoscopic Transsphenoidal Approach for Pituitary Adenomas: A Systematic Review and Meta-Analysis |
title_short | Mononostril versus Binostril Endoscopic Transsphenoidal Approach for Pituitary Adenomas: A Systematic Review and Meta-Analysis |
title_sort | mononostril versus binostril endoscopic transsphenoidal approach for pituitary adenomas: a systematic review and meta-analysis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849742/ https://www.ncbi.nlm.nih.gov/pubmed/27124276 http://dx.doi.org/10.1371/journal.pone.0153397 |
work_keys_str_mv | AT wenguodao mononostrilversusbinostrilendoscopictranssphenoidalapproachforpituitaryadenomasasystematicreviewandmetaanalysis AT tangchao mononostrilversusbinostrilendoscopictranssphenoidalapproachforpituitaryadenomasasystematicreviewandmetaanalysis AT zhongchunyu mononostrilversusbinostrilendoscopictranssphenoidalapproachforpituitaryadenomasasystematicreviewandmetaanalysis AT lixiang mononostrilversusbinostrilendoscopictranssphenoidalapproachforpituitaryadenomasasystematicreviewandmetaanalysis AT lijunyang mononostrilversusbinostrilendoscopictranssphenoidalapproachforpituitaryadenomasasystematicreviewandmetaanalysis AT liliwen mononostrilversusbinostrilendoscopictranssphenoidalapproachforpituitaryadenomasasystematicreviewandmetaanalysis AT yangyouqing mononostrilversusbinostrilendoscopictranssphenoidalapproachforpituitaryadenomasasystematicreviewandmetaanalysis AT machiyuan mononostrilversusbinostrilendoscopictranssphenoidalapproachforpituitaryadenomasasystematicreviewandmetaanalysis |